SignalEarnings

$VRTX — Develops therapies for cystic fibrosis and other serious diseases.

VRTX

$491.34

+2.32%

REGN

$632.90

+2.06%

BIIB

$216.03

+6.97%

What changed

$VRTX — Develops therapies for cystic fibrosis and other serious diseases. Q1: - Revenue: $2.99B - Adj EPS: $4.47 vs $4.31 🟢 - Adj operating margin: 38.1% (📈 +15.4pp YoY) Also in play: $REGN $BIIB $AMGN $GILD $INCY $LONN

Why it matters

Q1:

Sources

pipeline